Dingdang Health Announces Latest Buy-Back; 350,000 Shares Repurchased on 3 July, 13.88 Million Shares Await Cancellation

Bulletin Express07-03

Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed on 3 July 2026 that it repurchased 350,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 0.94 and HKD 0.96, for a total consideration of HKD 0.33 million. All of these shares are designated for cancellation rather than being held as treasury stock.

Since the current buy-back programme began on 19 May 2026, the company has acquired 13.88 million shares that remain pending cancellation. This volume represents approximately 1.11 % of Dingdang Health’s outstanding share capital of 1.25 billion shares as at the opening balance on 2 July 2026. Despite the ongoing cancellations, the issued share count stood unchanged at 1.25 billion as of 3 July 2026 because none of the repurchased shares had yet been retired from the register.

Under the general mandate approved on 23 June 2026, Dingdang Health is authorised to repurchase up to 124.32 million shares. As of 3 July 2026, the company had executed on-market repurchases totaling 2.40 million shares (0.19 % of issued shares) pursuant to this new mandate.

In line with Hong Kong Listing Rules, Dingdang Health is subject to a 30-day moratorium on new share issuance or treasury-share sales following the latest repurchase, extending through 2 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1144760704?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 19:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144760704","market":"us","top_or_hot":-1,"title":"Dingdang Health Announces Latest Buy-Back; 350,000 Shares Repurchased on 3 July, 13.88 Million Shares Await Cancellation","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed on 3 July 2026 that it repurchased 350,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 0.94 and HKD 0.96, for a total consideration of HKD 0.33 million. All of these shares are designated for cancellation rather than being held as treasury stock.</p>\n<p>Since the current buy-back programme began on 19 May 2026, the company has acquired 13.88 million shares that remain pending cancellation. This volume represents approximately 1.11 % of Dingdang Health’s outstanding share capital of 1.25 billion shares as at the opening balance on 2 July 2026. Despite the ongoing cancellations, the issued share count stood unchanged at 1.25 billion as of 3 July 2026 because none of the repurchased shares had yet been retired from the register.</p>\n<p>Under the general mandate approved on 23 June 2026, Dingdang Health is authorised to repurchase up to 124.32 million shares. As of 3 July 2026, the company had executed on-market repurchases totaling 2.40 million shares (0.19 % of issued shares) pursuant to this new mandate.</p>\n<p>In line with Hong Kong Listing Rules, Dingdang Health is subject to a 30-day moratorium on new share issuance or treasury-share sales following the latest repurchase, extending through 2 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Announces Latest Buy-Back; 350,000 Shares Repurchased on 3 July, 13.88 Million Shares Await Cancellation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Announces Latest Buy-Back; 350,000 Shares Repurchased on 3 July, 13.88 Million Shares Await Cancellation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-03 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed on 3 July 2026 that it repurchased 350,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 0.94 and HKD 0.96, for a total consideration of HKD 0.33 million. All of these shares are designated for cancellation rather than being held as treasury stock.</p>\n<p>Since the current buy-back programme began on 19 May 2026, the company has acquired 13.88 million shares that remain pending cancellation. This volume represents approximately 1.11 % of Dingdang Health’s outstanding share capital of 1.25 billion shares as at the opening balance on 2 July 2026. Despite the ongoing cancellations, the issued share count stood unchanged at 1.25 billion as of 3 July 2026 because none of the repurchased shares had yet been retired from the register.</p>\n<p>Under the general mandate approved on 23 June 2026, Dingdang Health is authorised to repurchase up to 124.32 million shares. As of 3 July 2026, the company had executed on-market repurchases totaling 2.40 million shares (0.19 % of issued shares) pursuant to this new mandate.</p>\n<p>In line with Hong Kong Listing Rules, Dingdang Health is subject to a 30-day moratorium on new share issuance or treasury-share sales following the latest repurchase, extending through 2 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1144760704","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144760704","pubTimestamp":1783077858,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed on 3 July 2026 that it repurchased 350,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 0.94 and HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康宣布最新回购；7月3日回购35万股1388万股等待注销","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed on 3 July 2026 that it repurchased 350,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 0.94 and HKD 0.96, for a total consideration of HKD 0.33 million. All of these shares are designated for cancellation rather than being held as treasury stock.\nSince the current buy-back programme began on 19 May 2026, the company has acquired 13.88 million shares that remain pending cancellation. This volume represents approximately 1.11 % of Dingdang Health’s outstanding share capital of 1.25 billion shares as at the opening balance on 2 July 2026. Despite the ongoing cancellations, the issued share count stood unchanged at 1.25 billion as of 3 July 2026 because none of the repurchased shares had yet been retired from the register.\nUnder the general mandate approved on 23 June 2026, Dingdang Health is authorised to repurchase up to 124.32 million shares. As of 3 July 2026, the company had executed on-market repurchases totaling 2.40 million shares (0.19 % of issued shares) pursuant to this new mandate.\nIn line with Hong Kong Listing Rules, Dingdang Health is subject to a 30-day moratorium on new share issuance or treasury-share sales following the latest repurchase, extending through 2 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1144760704","isCrawlerRequest":true}